Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study.

Authors:
Le Bourgeois M; Ferroni A; Leruez-Ville M; Varon E; Thumerelle C and 9 more

Journal:
J Pediatr

Publication Year: 2016

DOI:
10.1016/j.jpeds.2016.05.025

PMCID:
PMC7094675

PMID:
27339249

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Pediatr

Abbreviation: J Pediatr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pediatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cardiac Magnetic Resonance Findings of Coronavirus Disease 2019 (COVID-19) Vaccine-Associated Myope…
Dove ML; Slesnick TC; Oster ME and 3 more (2023) - Transparency Score: 3/6
The Impact of COVID-19 on Infant Maltreatment Emergency Department and Inpatient Medical Encounters.
Rebbe R; Reddy J; Kuelbs CL and 2 more (2023) - Transparency Score: 3/6
Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Co…
Campbell JI; Dubois MM; Savage TJ and 6 more (2022) - Transparency Score: 3/6
Effect of Outreach Messages on Adolescent Well-Child Visits and Coronavirus Disease 2019 Vaccine Ra…
Burkhardt MC; Berset AE; Xu Y and 2 more (2022) - Transparency Score: 4/6
Health Surveillance in a Down Syndrome Specialty Clinic: Implementation of Electronic Health Record…
Santoro SL; Howe YJ; Krell K and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Supported by the French National Clinical Research Program (AOM05103), DRRC Île-de-France, Assistance Publique–Hôpitaux de Paris and the French Agency of Health Products (2010-31), and the Agence Nationale de la Recherche, Labex Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID). The authors declare no conflicts of interest."

Evidence found in paper:

"Supported by the French National Clinical Research Program (AOM05103), DRRC Île-de-France, Assistance Publique–Hôpitaux de Paris and the French Agency of Health Products (2010-31), and the Agence Nationale de la Recherche, Labex Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID). The authors declare no conflicts of interest."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025